Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Language
Publication year range
1.
Can J Gastroenterol Hepatol ; 2019: 6963910, 2019.
Article in English | MEDLINE | ID: mdl-31214551

ABSTRACT

Introduction: Spontaneous bacterial peritonitis (SBP) has a deleterious clinical impact in end-stage liver disease, and multidrug resistance has increased, raising concern about effectiveness of traditional antibiotic regimens. Patients and Methods: Single-center retrospective study of ascitic fluid infections in cirrhotic patients. Results: We analyzed medical records related to 2129 culture-positive ascitic fluid and found 183 samples from cirrhotic patients. There were 113 monobacterial SBP cases from 97 cirrhotic patients; 57% of patients were male; hepatitis C and alcohol were the main etiologies for cirrhosis. Multidrug resistant bacteria were isolated in 46.9% of SBP samples, and third-generation cephalosporin and quinolone resistant reached 38.9% and 25.7% of SBP cases. Conclusion: SBP due to multidrug resistant bacteria is a growing problem, and one should consider reported resistance profiles for the decision-making process of empirical first-line treatment prescription.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Drug Resistance, Multiple, Bacterial , Liver Cirrhosis/complications , Peritonitis/microbiology , Adult , Aged , Ascitic Fluid/microbiology , Bacterial Infections/drug therapy , Female , Humans , Liver Cirrhosis/microbiology , Liver Cirrhosis/therapy , Male , Middle Aged , Peritonitis/drug therapy , Peritonitis/epidemiology , Prevalence , Retrospective Studies
2.
Clin. biomed. res ; 34(2): 139-144, 2014. ilus, tab, graf
Article in English | LILACS | ID: biblio-997814

ABSTRACT

INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2 DS2 -VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies


Subject(s)
Humans , Atrial Fibrillation/drug therapy , Time Factors , Anticoagulants/administration & dosage , Outpatients , Follow-Up Studies , Ischemic Preconditioning , Anticoagulants/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...